| pubmed-article:431177 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:431177 | lifeskim:mentions | umls-concept:C0341628 | lld:lifeskim |
| pubmed-article:431177 | lifeskim:mentions | umls-concept:C0024141 | lld:lifeskim |
| pubmed-article:431177 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:431177 | pubmed:dateCreated | 1979-6-29 | lld:pubmed |
| pubmed-article:431177 | pubmed:abstractText | Thirty-three cases of systemic lupus erythematosus in women are studied in retrospect. Eight patients (24 percent) presented a total of ten neuropsychiatric episodes that could be attributed to the underlying disease. The neuropsychiatric manifestation that was most often observed was cerebrovascular stroke (40 percent) followed by psychic disturbances and convulsions. A facial paralysis coinciding with an hypertensive crisis was noticed in one case. Another patient presented a peripheral sensitive neuropathy. Five episodes occurred prior to diagnosis or during the first year of the disease. In two patients the neuropsychiatric manifestations constituted the initial symptom of systemic lupus erythematosus. ECG proved to be one of the most valuable diagnostic tools among the complementary studies. It was altered in cases of organic pathology and normal when disturbances were of psychic origin. The C3 fraction of the serum complement revealed a definite difference between patients with and without neuropsychiatric manifestations. Concentrations were lower in persons which psychic disturbances than in patients without them. The pathogenesis of neuropsychiatric manifestations of systemic lupus erythematosus is discussed. They cannot be attributed exclusively to coagulation disturbances nor to treatment with corticosteroids. The immediate prognosis of neuropsychiatric episodes was good: there was partial or total recuperation in eight of the ten episodes. However, the long-term course of systemic lupus erythematosus shows that these manifestations represent an unfavourable prognostic factor in this disease. | lld:pubmed |
| pubmed-article:431177 | pubmed:language | spa | lld:pubmed |
| pubmed-article:431177 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:431177 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:431177 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:431177 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:431177 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:431177 | pubmed:issn | 0025-7753 | lld:pubmed |
| pubmed-article:431177 | pubmed:author | pubmed-author:Gil AguadoAA | lld:pubmed |
| pubmed-article:431177 | pubmed:author | pubmed-author:BarbadoJJ | lld:pubmed |
| pubmed-article:431177 | pubmed:author | pubmed-author:VázquezJ JJJ | lld:pubmed |
| pubmed-article:431177 | pubmed:author | pubmed-author:García PuigJJ | lld:pubmed |
| pubmed-article:431177 | pubmed:author | pubmed-author:García... | lld:pubmed |
| pubmed-article:431177 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:431177 | pubmed:day | 25 | lld:pubmed |
| pubmed-article:431177 | pubmed:volume | 72 | lld:pubmed |
| pubmed-article:431177 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:431177 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:431177 | pubmed:pagination | 133-8 | lld:pubmed |
| pubmed-article:431177 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:431177 | pubmed:meshHeading | pubmed-meshheading:431177-H... | lld:pubmed |
| pubmed-article:431177 | pubmed:meshHeading | pubmed-meshheading:431177-D... | lld:pubmed |
| pubmed-article:431177 | pubmed:meshHeading | pubmed-meshheading:431177-A... | lld:pubmed |
| pubmed-article:431177 | pubmed:meshHeading | pubmed-meshheading:431177-L... | lld:pubmed |
| pubmed-article:431177 | pubmed:meshHeading | pubmed-meshheading:431177-S... | lld:pubmed |
| pubmed-article:431177 | pubmed:meshHeading | pubmed-meshheading:431177-F... | lld:pubmed |
| pubmed-article:431177 | pubmed:meshHeading | pubmed-meshheading:431177-P... | lld:pubmed |
| pubmed-article:431177 | pubmed:meshHeading | pubmed-meshheading:431177-F... | lld:pubmed |
| pubmed-article:431177 | pubmed:meshHeading | pubmed-meshheading:431177-M... | lld:pubmed |
| pubmed-article:431177 | pubmed:meshHeading | pubmed-meshheading:431177-E... | lld:pubmed |
| pubmed-article:431177 | pubmed:meshHeading | pubmed-meshheading:431177-C... | lld:pubmed |
| pubmed-article:431177 | pubmed:meshHeading | pubmed-meshheading:431177-A... | lld:pubmed |
| pubmed-article:431177 | pubmed:meshHeading | pubmed-meshheading:431177-M... | lld:pubmed |
| pubmed-article:431177 | pubmed:meshHeading | pubmed-meshheading:431177-C... | lld:pubmed |
| pubmed-article:431177 | pubmed:year | 1979 | lld:pubmed |
| pubmed-article:431177 | pubmed:articleTitle | [Neuropsychic manifestations in systemic lupus erythematosus (author's transl)]. | lld:pubmed |
| pubmed-article:431177 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:431177 | pubmed:publicationType | English Abstract | lld:pubmed |
